Overview

Safety Study of Intravenous 6β-Naltrexol (AIKO-150) in Opioid-Dependent Subjects

Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of intravenous 6β-Naltrexol administered to opiate dependent subjects
Phase:
Phase 1
Details
Lead Sponsor:
California Pacific Medical Center Research Institute
Treatments:
Analgesics, Opioid
Lactulose
Naloxone